Injectable Influenza Vaccine
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency Troop Support is seeking a contractor to supply approximately 1.5 million doses of injectable influenza vaccines in prefilled syringes for the 2027-2028 flu season. The vaccines must be FDA-approved and recommended by the CDC Advisory Committee on Immunization Practices, covering age groups ranging from 6 months to 65 years and older. This is an indefinite quantity contract with a guaranteed minimum of 75 percent and a maximum of 150 percent of the annual estimate. Deliveries are to be made to the Defense Depot in New Cumberland, Pennsylvania, following a preferred schedule that begins August 12, 2027, and concludes by September 23, 2027. The solicitation is projected for October 2026, and interested parties can find further details on SAM.gov and the DLA Bid Board System. Primary coordination for this requirement is managed by Rosbert Jones.
General Info
Agency
NAICS
Place of Performance
PA, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2027-2028 flu season. Approximately 1.5 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and for immunizing 6 months to 35 months (pediatric group).
The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended. National Stock Numbers shall be established at the time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 12, 2027, 25% by August 26, 2027, 25% by September 9, 2027, and the residual 10% by September 23, 2027. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (445-737-1254) (Rosbert.Jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is October of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
